Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with multiple sclerosis

Published:2013-09-25 Issue:12 Volume:29 Page:1627-1636
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Weir Scott¹,Torkin Risa²,Henney III Herbert R.²

Affiliation:

1. University of Kansas Cancer Center Kansas City, KSUSA

2. Acorda Therapeutics Inc. Ardsley, NYUSA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2012.749221

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HPLC method development for fampridine using Analytical Quality by Design approach;Acta Pharmaceutica;2020-05-13

2. Guía de tratamiento del deterioro de la marcha con fampridina de liberación prolongada (Fampyra ® ) en pacientes con esclerosis múltiple;Neurología;2018-06

3. A guide to treating gait impairment with prolonged-release fampridine (Fampyra ® ) in patients with multiple sclerosis;Neurología (English Edition);2018-06

4. Comparative Randomized, Single‐Dose, Two‐Way Crossover Open‐Label Study to Determine the Bioequivalence of Two Formulations of Dalfampridine Tablets;Clinical Pharmacology in Drug Development;2018-05-11

5. Development of a PET radioligand for potassium channels to image CNS demyelination;Scientific Reports;2018-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP